Kehoe PG - Search Results

1

The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project.

Combarros O, Warden DR, Hammond N, Cortina-Borja M, Belbin O, Lehmann MG, Wilcock GK, Brown K, Kehoe PG, Barber R, Coto E, Alvarez V, Deloukas P, Gwilliam R, Heun R, Kölsch H, Mateo I, Oulhaj A, Arias-Vásquez A, Schuur M, Aulchenko YS, Ikram MA, Breteler MM, van Duijn CM, Morgan K, Smith AD, Lehmann DJ. Combarros O, et al. Among authors: kehoe pg. BMC Med Genet. 2010 Nov 11;11:162. doi: 10.1186/1471-2350-11-162. BMC Med Genet. 2010. PMID: 21070631 Free PMC article.

2

Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.

Kehoe P, Williams J, Lovestone S, Wilcock G, Owen MJ. Kehoe P, et al. Lancet. 1996 Apr 27;347(9009):1185. Lancet. 1996. PMID: 8609781 No abstract available.

3

Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease.

Kehoe P, Williams J, Holmans P, Liddell M, Lovestone S, Holmes C, Powell J, Neal J, Wilcock G, Owen MJ. Kehoe P, et al. Neuroreport. 1996 Sep 2;7(13):2155-8. doi: 10.1097/00001756-199609020-00019. Neuroreport. 1996. PMID: 8930979

4

The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.

Kehoe PG, Williams H, Holmans P, Wilcock G, Cairns NJ, Neal J, Owen MJ. Kehoe PG, et al. J Med Genet. 1998 Dec;35(12):1034-5. doi: 10.1136/jmg.35.12.1034. J Med Genet. 1998. PMID: 9863603 Free PMC article.

5

Haplotypes extending across ACE are associated with Alzheimer's disease.

Kehoe PG, Katzov H, Feuk L, Bennet AM, Johansson B, Wiman B, de Faire U, Cairns NJ, Wilcock GK, Brookes AJ, Blennow K, Prince JA. Kehoe PG, et al. Hum Mol Genet. 2003 Apr 15;12(8):859-67. doi: 10.1093/hmg/ddg094. Hum Mol Genet. 2003. PMID: 12668609

6

Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.

Culpan D, MacGowan SH, Ford JM, Nicoll JA, Griffin WS, Dewar D, Cairns NJ, Hughes A, Kehoe PG, Wilcock GK. Culpan D, et al. Among authors: kehoe pg. Neurosci Lett. 2003 Oct 16;350(1):61-5. doi: 10.1016/s0304-3940(03)00854-1. Neurosci Lett. 2003. PMID: 12962917

7

Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease.

Kehoe PG, Katzov H, Andreasen N, Gatz M, Wilcock GK, Cairns NJ, Palmgren J, de Faire U, Brookes AJ, Pedersen NL, Blennow K, Prince JA. Kehoe PG, et al. Hum Genet. 2004 Apr;114(5):478-83. doi: 10.1007/s00439-004-1093-y. Epub 2004 Feb 17. Hum Genet. 2004. PMID: 14986105

8

Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism.

Katzov H, Chalmers K, Palmgren J, Andreasen N, Johansson B, Cairns NJ, Gatz M, Wilcock GK, Love S, Pedersen NL, Brookes AJ, Blennow K, Kehoe PG, Prince JA. Katzov H, et al. Among authors: kehoe pg. Hum Mutat. 2004 Apr;23(4):358-67. doi: 10.1002/humu.20012. Hum Mutat. 2004. PMID: 15024730

9

APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease.

Chalmers KA, Culpan D, Kehoe PG, Wilcock GK, Hughes A, Love S. Chalmers KA, et al. Among authors: kehoe pg. Neuroreport. 2004 Jan 19;15(1):95-8. doi: 10.1097/00001756-200401190-00019. Neuroreport. 2004. PMID: 15106838

10

Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.

Blomqvist ME, Chalmers K, Andreasen N, Bogdanovic N, Wilcock GK, Cairns NJ, Feuk L, Brookes AJ, Love S, Blennow K, Kehoe PG, Prince JA. Blomqvist ME, et al. Among authors: kehoe pg. Neurobiol Aging. 2005 Jun;26(6):795-802. doi: 10.1016/j.neurobiolaging.2004.07.011. Neurobiol Aging. 2005. PMID: 15718037 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page